navarrete et al 2009
TRANSCRIPT
SHORT COMMUNICATION
Protective effect of fallopian tubal fluid against activatedleucocyte-induced sperm DNA fragmentation: preliminaryresultsP. Navarrete Gomez1,6, J. Espinoza Ruiz1,5, J. Parodi Rivera1, J. G. Alvarez2,3 & R. Sanchez Gutierrez4
1 Centro de Excelencia de Biotecnologıa de la Reproduccion (CEBIOR), Universidad de La Frontera, Temuco, Chile;
2 Instituto Marques, Barcelona, Barcelona, Spain;
3 Fundacion Leonardo Marques, Barcelona, Spain;
4 Departamento de Ciencias Preclınicas, Universidad de La Frontera, Temuco, Chile;
5 Tesista y;
6 Estudiante del Programa de Doctorado en Ciencias Mencion Biologıa Celular y Molecular Aplicada, Becarios CONICYT
Introduction
The integrity of the paternal genome is vital to the onset
and maintenance of a viable pregnancy to term
(Angelopoulou et al., 2007). The previous studies have
shown that exposure of human spermatozoa to tubal/
oviductal epithelial cells protects them from ROS-induced
damage, thus increasing sperm survival (El Mouatassim
et al., 2000). Despite all these studies, however, it is still
not known whether the oviduct exerts a protective effect
on sperm DNA fragmentation. The primary aim of this
study was to determine if human tubal explants or tubal
fluid exert a protective effect against ROS-induced sperm
DNA damage.
Materials and methods
Tubal explants were obtained from the fallopian tubes of
four healthy women subjected to hysterectomy. Tubal
fluid was obtained from the explants and incubated at
37 �C for 24 h in supplemented DMEM medium
(sDMEM). Semen samples were obtained from healthy
donors, processed for standard swim-up and incubated
with tubal fluid during 12 h.
Keywords:
Activated leucocytes—DNA
fragmentation—human sperm—ROS—
tubal fluid
Correspondence
Dr Raul Sanchez Gutierrez, Facultad de
Medicina, Universidad de La Frontera, Manuel
Montt 112, Temuco, Chile.
Tel.: +56 45 744248;
Fax: +56 45 325600;
E-mail: [email protected]
Accepted: January 13, 2009
Summary
The integrity of the paternal genome is of paramount importance in the initia-
tion and maintenance of a viable pregnancy. Oxygen radicals (ROS) have been
identified as one of the main factors responsible for the induction of sperm
DNA damage. Spermatozoa are mainly protected against ROS-induced damage
by seminal plasma. However, this protective effect disappears once spermatozoa
enter the female genital tract. The fallopian tube mucosa may play a protective
role against ROS-induced sperm damage. The main objective of this study was
to determine whether human tubal explants and tubal fluid exert a protective
effect on ROS-induced sperm DNA damage. Spermatozoa were exposed to
tubal explants and/or tubal fluid in the presence of phorbol myristate acetate
(PMA)-activated polymorphonuclear leucocytes or control medium and sperm
DNA fragmentation was measured using the TdT-mediated dUTP-biotin nick
end labelling (TUNEL) test. Exposure of human spermatozoa to PMA-activated
leucocytes resulted in a 2-fold increase in sperm DNA fragmentation. Co-incu-
bation of spermatozoa with tubal explants did not reduce this damage.
However, pre-incubation of spermatozoa with tubal fluid resulted in a statis-
tically significant reduction in sperm DNA fragmentation levels, comparable to
those observed in control. In conclusion, tubal fluid appears to protect against
activated leucocyte-induced sperm DNA fragmentation, thus preserving the
integrity of the paternal genome.
196 ª 2009 Blackwell Verlag GmbH Æ Andrologia 41, 196–198
Polymorphonuclear (PMN) leucocytes were activated
with phorbol-12-miristate-13-acetate (PMA). Sperm DNA
fragmentation was determined using the TUNEL test
according to the manufacturer’s instructions (Roche,
Grenzach-Wyhlen, Germany). Following TUNEL labelling,
propidium iodide was added and the samples analysed by
flow cytometry. TUNEL test data were analysed using the
graphpad prism 5.0 program (GraphPad Software, La
Jolla, CA, USA).
Differences between the groups were analysed using the
Kruskal–Wallis and Dunn’s post-tests. A P-value less than
0.05 (P < 0.05) was considered as statistically significant.
Results and discussion
Incubation of human spermatozoa in sDMEM did not
result in any significant increase in DNA fragmentation
compared with the control with HTF medium (P > 0.05)
(Fig. 1a). Treatment with DNAse I produced a fragmenta-
tion level of 95 ± 3.06% (P < 0.05). Incubation of human
spermatozoa with activated leucocytes resulted in an
increase in DNA fragmentation levels, although these dif-
ferences were not statistically significant (P > 0.05).
Moreover, incubation of the spermatozoa with PMN,
PMA and DMSO did not produce any significant effect
(P > 0.05) on sperm DNA fragmentation. Incubation of
human spermatozoa with tubal explants produced a sig-
nificant decrease in sperm DNA fragmentation levels dur-
ing incubation at 37 �C (P < 0.05) (Fig. 1b), whereas
incubation of human spermatozoa with tubal medium
did not result in any significant effect on sperm DNA
fragmentation (P > 0.05). Incubation with activated leu-
cocytes did not produce any significant decrease
(P > 0.05) in activated leucocyte-induced sperm DNA
fragmentation levels, whereas incubation with tubal fluid,
after incubation with activated leucocytes, produced a sig-
nificant decrease in sperm DNA fragmentation levels
(P < 0.05) comparable to those observed in the control
(Fig. 1c).
The main findings of this study are that (i) tubal ex-
plants decrease sperm DNA fragmentation during incuba-
tion at 37 �C, whereas tubal fluid had no effect; and (ii)
tubal fluid prevents sperm DNA fragmentation induced
by PMA-activated leucocytes, whereas tubal explants had
no effect. The previous studies have shown that human
spermatozoa can establish direct contact with the tubal
epithelium and that this contact increases motility, pre-
vents the premature acrosome reaction and increases the
fertility capacity of spermatozoa (Morales et al., 1996;
Green et al., 2001). This could be related to a possible
antioxidant effect of the tubal cells that would neutralise
the ROS produced by spermatozoa in the extracellular
medium. In contrast, the tubal explants’ lack of protective
effect on activated leucocyte-induced sperm DNA frag-
mentation might be related to tubal cell damage induced
by the specific ROS produced by activated leucocytes,
which could inactivate enzymatic antioxidant defences of
these cells. In the case of tubal fluid, the antioxidant
defences would be mainly nonenzymatic soluble factors
that are not susceptible to inactivation by the high levels
(a)
(b)
(c)
Fig. 1 Effect of incubation in sDMEM, tubal explants (TU) or tubal
fluid (CM) on sperm DNA fragmentation. (a) Percentage of TUNEL-
positive spermatozoa after incubation in sDMEM (*P < 0.05); (b) Per-
centage of TUNEL-positive spermatozoa after incubation with TU or
CM; (c) Percentage of TUNEL-positive spermatozoa after incubation
with tubal TU or CM prior to incubation with activated leucocytes and
their respective controls.
P. Navarrete Gomez et al. Tubal fluid protects against sperm DNA damage
ª 2009 Blackwell Verlag GmbH Æ Andrologia 41, 196–198 197
of ROS produced by the activated leucocytes. Studies are
underway to try to answer the question of why the tubal
fluid protects against activated leucocyte-induced DNA
damage and not that produced during incubation with
nonactivated leucocytes.
References
Angelopoulou A, Plastira K, Msaouel P (2007) Spermatozoal
sensitive biomarkers to defective protaminosis and frag-
mented DNA. Reprod Biol Endocrinol 5:1–15.
El Mouatassim S, Guerin P, Menezo Y (2000) Mammalian
oviduct and protection against free oxygen radicals:
expression of genes encoding antioxidant enzymes in
human and mouse. Eur J Obstet Gynecol Reprod Biol 89:
1–6.
Green CE, Bredl J, Holt WV, Watson PF, Fazeli A (2001)
Carbohydrate mediation of boar sperm binding to oviductal
epithelial cells in vitro. Reproduction 122:305–315.
Morales P, Palma V, Salgado AM, Villalon M (1996) Sperm
interaction with human oviductal cells in vitro. Hum Reprod
11:1504–1509.
Tubal fluid protects against sperm DNA damage P. Navarrete Gomez et al.
198 ª 2009 Blackwell Verlag GmbH Æ Andrologia 41, 196–198